SINOPEP-ALLSINO BIOPHARMACEUTICAL CO LTD

SINOPEP-ALLSINO BIOPHARMACEUTICAL CO LTD (China) holds 24 active US FDA Type II Drug Master Files and 3 inactive, has DMF or CEP filings on record for 20 active ingredients and is linked to 1 FDA-registered manufacturing site. No FDA recall, Warning Letter or Form 483 record is linked to it, which is not proof that none exists.

Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records

Cite as: PharmaTek, “SINOPEP-ALLSINO BIOPHARMACEUTICAL CO LTD: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/sinopep-allsino-biopharmaceutical-co-ltd

Overview

SINOPEP-ALLSINO BIOPHARMACEUTICAL CO LTD is an active pharmaceutical ingredient (API) supplier with 23 active FDA Type II Drug Master Files, covering BALOXAVIR MARBOXIL; BIVALIRUDIN; CAGRILINTIDE; CETRORELIX ACETATE; DESMOPRESSIN ACETATE; DMT-2'FLUORO-DA(BZ) AMIDITE.

Core services & business areas

API Manufacturing

Active ingredients with DMF or CEP filings

Substances for which SINOPEP-ALLSINO BIOPHARMACEUTICAL CO LTD holds, or has held, a US FDA Drug Master File or an EU CEP. A filing is not proof of current supply. Open any ingredient to see all its holders, CAS number and product patent dates.

API / Drug Master Files

SINOPEP-ALLSINO BIOPHARMACEUTICAL CO LTD holds 24 active (27 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.

  • DIFELIKEFALIN ACETATEActive2026-09-04
  • CAGRILINTIDEActive2026-03-26
  • RETATRUTIDEActive2026-03-19
  • SEMAGLUTIDE (SEMI-SYNTHETIC)Active2025-12-29
  • RISDIPLAM INTERMEDIATE (CAS NO.: 2133298-74-3)Active2025-12-11
  • SEMAGLUTIDEActive2025-12-01
  • DMT-2'FLUORO-DA(BZ) AMIDITEActive2025-10-29
  • ICOTROKINRAActive2025-08-29
  • ORFORGLIPRONActive2025-04-27
  • BALOXAVIR MARBOXILActive2025-04-18
  • ELACESTRANT DIHYDROCHLORIDEActive2025-03-26
  • RISDIPLAMActive2024-09-23
  • TIRZEPATIDEActive2024-02-06
  • DESMOPRESSIN ACETATEActive2023-01-16
  • FULVESTRANT INTERMEDIATE (CAS NO.: 875573-66-3)Active2022-09-01
  • SEMAGLUTIDEActive2021-11-01
  • OSELTAMIVIR INTERMEDIATE (CAS No.: 651324-08-2)Active2021-09-22
  • CETRORELIX ACETATEActive2020-09-29
  • OSELTAMIVIR PHOSPHATEActive2020-04-30
  • FULVESTRANTActive2020-03-26
  • LIRAGLUTIDEActive2019-09-19
  • BIVALIRUDINActive2018-06-29
  • OCTREOTIDE ACETATEActive2017-10-12
  • LANREOTIDE ACETATEActive2016-08-16
  • BIVALIRUDIN (PROCESS II)Inactive2020-09-30
  • LIRAGLUTIDEInactive2018-09-05
  • DECOQUINATEInactive2017-02-12

Registered manufacturing sites (1)

Physical sites registered with the US FDA and resolved to SINOPEP-ALLSINO BIOPHARMACEUTICAL CO LTD, with any EU/UK GMP documents matched to each site. Headquarters and manufacturing locations can differ.

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to SINOPEP-ALLSINO BIOPHARMACEUTICAL CO LTD in our records. Events are linked by company name and identifier, so this is not proof that none exist; check the FDA's own databases before relying on it.

For suppliers

Is this SINOPEP-ALLSINO BIOPHARMACEUTICAL CO LTD?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.

Need suppliers found and checked?

The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.